More Business Wire
View Older Stories View Newer Stories-
AEye to Report Fourth Quarter 2023 Financial Results on Tuesday, March 26
-
Intellicheck to Announce Fourth Quarter and Full Year 2023 Financial Results
-
Mindbreeze is Included Again in the 2024 KMWorld Top 100 Companies Impacting Knowledge Management
-
Yerbaé Announces New Distribution Partnerships with Pure Beverages and Terborg Distributing
-
Sabanci University Will Host the "Sakura Festival" on the 100th Anniversary of the Establishment of Diplomatic Relations Between Turkey and Japan
-
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Tide Partners with Electrolux, GE Appliances and Samsung to Announce the First Tide Cold Certified Washing Machines
-
Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs
-
Surface Ophthalmics Announces New Leadership with Richard Lindstrom, MD, and Renewed Vision for Addressing Critical Unmet Needs of Dry Eye Syndrome Patients
-
Options Technology Achieves Microsoft Cloud Security Specialization, Solidifying Commitment to Excellence in Security Solutions
-
Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs
-
Salient Unveils Next-Generation Weather Forecasting Model to Transform Risk Management
-
Global Indemnity Group, LLC Reports Year Ended 2023 Results
-
Affini-T Therapeutics to Present Preclinical Data from its Programs Targeting KRAS G12D and p53 R175H and Two Trials in Progress at the American Association for Cancer Research (AACR) Annual Meeting
-
Vizgen Announces Denial of 10x Genomics’ Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted Against 10x’s Xenium Platform
-
Autobahn Therapeutics to Present at the Stifel 2024 Virtual CNS Days
-
Land & Buildings Calls on Equity Commonwealth to Take Long Overdue Step of Liquidating Remaining Assets and Returning Capital to Shareholders
-
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
-
Sagard and HalseyPoint Asset Management Enter Into Strategic Partnership
-
Cognito Therapeutics Announces Oral Presentation at 2024 American Academy of Neurology (AAN) Annual Meeting
-
Critical Infrastructure Cybersecurity Expert Aaron Crow Joins MorganFranklin Consulting
-
Stellar Cyber and Torq Partner to Deliver Automation-Driven Security Operations Platform
-
Verato Enables Healthcare to Know Who is Who with Google Cloud
-
SetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
-
InsurSec Leader At-Bay Appoints Martina Trucco as Chief Marketing Officer
-
11:59 and Tungsten Automation Partner to Deliver Intelligent Automation Solutions
-
Black Bear Diner Extends Bears Brew Back® Initiative to Donate Proceeds from Coffee Blend Grown and Roasted by Women, Back to Women During Women’s History Month
-
Canoe Intelligence Unveils Canoe Asset Data Following Completion of Design Partnership with 13 Clients
-
Biosero Appoints Daniel Schumann as Chief Operations Officer
-
TELO Announces $5.4M Strategic Fundraise Led by Neo to Continue Building the Most Efficient Electric Truck
-
Spotnana Revolutionizes Travel Management for In-Person Gatherings with New Events Product
-
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation
-
RapidCanvas Exits Stealth with $7.5 Million in Seed Funding to Empower Business Users with AutoAI platform
-
Transform Pharmaceutical Authoring Processes With Fonto Integrated Authoring Platform
-
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
-
Celestial AI to Showcase Photonic Fabric™ Optical Interconnect Platform for AI Computing and Memory Infrastructure at OFC 2024
-
MassMutual Research: Most Retirees are Happier in Retirement vs. Working Thanks to Financial Preparation, but More than One Third Report Feeling Lonely
-
Akuity Introduces Security-Hardened Argo CD for Supercharging GitOps Practices with Unmatched Security
-
Aria Systems Launches Aria Billing Studio to Optimize Billing Management and AI Capabilities Within Salesforce
-
WorldQuant Predictive Appoints Amir Husain as Chairman of the Board
-
Schwab Asset Management Announces Index and Fund Name Changes to Its Fundamental Index ETF and Mutual Fund Family
-
Motus Gains Momentum With New CRO, Platform Enhancements, and Multiple Industry Award Wins
-
Browzwear Strengthens Leadership Team with Appointment of Greg Hanson as Chief Operating Officer
-
Aptus Capital Advisors Announces Addition of Brian Jacobs, CFA, and Brett Bennett, CFA
-
Customer Testing of Evolv Guides Purchase Decisions as Millions Enjoy a Better Security Experience
-
CQL Announces New Leadership and Strategic Growth Investment from Superstep Capital
-
The Medical University of South Carolina and Flatiron Health Announce Collaboration to Drive More Standardized, Efficient, and Effective Cancer Care
-
Installed Building Products Announces Plans to Refinance and Extend its Term Loan B Facility
-
Sapia.ai Unveils SAIGE™: A world-first Gen AI-powered conversational intelligence engine for talent management
-
NSU Foundation Announces Record Fund Raising And Endowment Performance Success
